Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug JADE101 tested in healthy volunteers for first time

NCT ID NCT07525947

Recruiting now Knowledge-focused Sponsor: Jade Biosciences, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Phase 1 trial is testing a single dose of JADE101 in 40 healthy Japanese and Chinese adults to see if it is safe and how the body processes it. Researchers will monitor side effects and measure drug levels in the blood. This is an early step to gather basic safety information before testing the drug in people with a disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

JADE101

What could go wrong

This is a very early Phase 1 study in healthy people, so it cannot show whether JADE101 works for any disease. Many drugs fail in early testing.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS (HV) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY VOLUNTEERS (HV)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Parexel Early Phase Clinical Unit (EPCU)

    RECRUITING

    Glendale, California, 91206, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••